Pharmafile Logo
Pharmafocus logo
Advanced Search

Pfizer

Showing 15 posts of 894 posts found.

Pfizer-BioNTech COVID-19 vaccine likely to protect against UK variant, study says

January 20, 2021
Research and Development COVID-19, Pfizer

The Pfizer-BioNTech COVID-19 vaccine is likely to protect against the coronavirus variant found in Britain, the latest research says. The …

News
credit_-_daniel_leal-olivas-afp

COVID-19 vaccine data leaked online by hackers, EMA says

January 14, 2021
EMA, Pfizer, Vaccine, data

The EMA has confirmed that data relating to COVID-19 medicines and vaccines that was stolen by hackers in December have …

News

Pfizer invests $25m in Vedanta BioSciences’ IBD treatment

January 13, 2021
Research and Development Pfizer, Vedanta Biosciences, inflammatory bowel disease

Pfizer has invested $25 million in Vedanta Biosciences, a clinical-stage company developing a new category of therapies for immune-mediated diseases, …

News

Pfizer’s COVID-19 vaccine protects against variants, research shows

January 8, 2021
Medical Communications COVID-19, Pfizer, Vaccine

Pfizer’s COVID-19 vaccine is effective against the two fast-spreading variants of the virus that emerged in the UK and South …

News
pfizer_building_logo1

EU states to receive 100m extra doses of Pfizer-BioNTech vaccine

January 4, 2021
Sales and Marketing COVID-19, EU, Pfizer, Vaccine

Pfizer and BioNTech have announced they will supply an additional 100 million doses of their COVID-19 vaccine, COMIRNATY, to the …

News

BioInvent receives $3m payment for antibodies selected by Pfizer

December 23, 2020
Research and Development BioInvent, Cancer, Pfizer

BioInvent International, a biotech company focused on the discovery and development of novel and first-in-class immune-modulatory antibodies for cancer immunotherapy, …

News

Pfizer and Moderna test COVID-19 vaccines against new strain

December 22, 2020
Manufacturing and Production COVID-19, Moderna, Pfizer, Vaccine

Pfizer and Moderna have begun testing their COVID-19 vaccines against the new, fast-spreading strain of the virus that was recently …

News
credit_-_daniel_leal-olivas-afp

EU gives green light to Pfizer-BioNTech COVID-19 vaccine

December 22, 2020
Manufacturing and Production COVID-19, EMA, Pfizer, Vaccine

The EMA has recommended the Pfizer-BioNTech COVID-19 vaccine for use across the EU’s 27 countries, with the first doses set …

News

FDA says Pfizer vaccine vials contain extra doses, boosting US supply

December 17, 2020
Sales and Marketing COVID-19, FDA, Pfizer, Vaccine

The FDA has announced that extra doses contained in Pfizer COVID-19 vaccine vials could expand America’s supply of the jab …

News
bavencio_merck_large

Pfizer and Merck KGaA secure CHMP recommendation for Bavencio in Europe for first-line maintenance of urothelial carcinoma

December 14, 2020
Sales and Marketing Bavencio, CHMP, EMA, Merck, Pfizer, pharma, urothelial carcinoma

The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has given its recommendation for …

News
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

December 11, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, COVID-19, Pfizer, Vaccine, pharma, top 10

With just around three weeks until the end of a long year, rapidly emerging news around the leading COVID-19 vaccine …

News
88222

UK becomes first nation to approve Pfizer and BioNTech’s COVID-19 vaccine

December 2, 2020
Research and Development, Sales and Marketing COVID-19, Pfizer, UK, Vaccine

The UK has become the first country worldwide to authorise Pfizer and BioNTech’s promising COVID-19 vaccine, the UK Government has …

News
1

EMA receives Pfizer and BioNTech’s filing for conditional approval of COVID-19 vaccine in Europe

December 1, 2020
Manufacturing and Production, Sales and Marketing BioNTech, COVID-19, EMA, Pfizer, Vaccine

Pfizer and BioNTech have officially submitted their application to secure conditional marketing authorisation to the European Medicines Agency (EMA) for …

News
fdaoutsideweb

Pfizer and BioNTech to request FDA Emergency Use Authorisation for their COVID-19 vaccine today

November 20, 2020
Medical Communications, Sales and Marketing BioNTech, COVID-19, Pfizer, Vaccine

Pfizer and BioNTech are reportedly gearing up to submit a formal application for Emergency Use Authorisation to the FDA later …

News
vaccination-1215279_960_720

Pfizer/BioNTech’s COVID-19 vaccine shows up to 95% efficacy in final analysis, including in over-65s

November 18, 2020
Research and Development BioNTech, COVID-19, Pfizer, Vaccine

Pfizer and BioNTech have backed up their promising interim Phase 3 data showing 90% efficacy for their COVID-19 vaccine candidate …

News
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026